| Project/Area Number |
16H07094
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
General surgery
|
|---|
| Research Institution | University of the Ryukyus |
|---|
Principal Investigator |
NAKASHIMA YOSHIKI 琉球大学, 医学(系)研究科(研究院), 助教 (30593082)
|
|---|
| Project Period (FY) |
2016-08-26 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 移植・再生医療 / 発生・分化 / 細胞・組織 / バイオリアクター / 再生医学 / シグナル伝達 |
|---|
| Outline of Final Research Achievements |
Regenerative medicine is expected as a new treatment method that can cure disease that could not be cured so far. Regenerative medicine using iPS cells invented by Professor Shinya Yamanaka in regenerative medicine is expected to be able to treat many diseases of the whole body. However, iPS cells had a risk of developing tumors in the body. The risk can be prevented by removing most of the iPS cells from the therapeutic cells. In this study, we were able to discover drugs that can almost remove iPS cells from therapeutic cells. And it was also found that the drug is not toxic to body cells. By using this research result to the world, it becomes possible to safely perform new treatments using iPS cells.
|
